Kidney Infection Market Business Growth, Size and Comprehensive Research Study Forecast to 2027


Kidney infection is a result of infection in the bladder that spreads to the kidney. Most common bacteria causing kidney infection is E. coli. Kidney infections are very common, especially, an aging population.

The global kidney infection market is projected to grow at a 5.2% CAGR between 2017-2023, as per the recent Market Research Future (MRFR) report. Kidney infection, also known as pyelonephritis, often occurs from infections in the urinary tract, which spreads to the kidneys. These infections can be chronic or sudden, and if not treated at the right time, can be painful and life-threatening. Nausea and vomiting, fever, back pain, pain while urinating, smelly or cloudy urine, and blood in the urine are some of the common symptoms of kidney infection.

Numerous factors are adding to the global kidney infection market growth. These factors, according to the recent Market Research Future report, comprise the introduction of new services and products by key players in emerging economies and developing countries, rising geriatric population, good investments in new technology development, increased application, and favorable reimbursement policies. Additional factors adding to the market growth include a growing need for better treatment methods, increasing investments in RD by pharmaceutical and biotechnology industries, and the rising prevalence of kidney infections.

On the contrary, high treatment costs may deter the global kidney infection market growth during the forecast period.

Get Sample Copy of Report @ https://www.marketresearchfuture.com/sample_request/5192 

Key Players

Leading players profiled in the global kidney infection market report include Teva Pharmaceutical Industries Ltd. (Japan), Sanofi (France), Pfizer (U.S.), Kissei Pharmaceutical Co. Ltd. (Japan), Keryx Biopharmaceuticals, Inc. (U.S.), Johnson Johnson Services Inc. (U.S.), GlaxoSmithKline plc. (U.K), F. Hoffmann-La Roche Ltd (Switzerland), AstraZeneca (U.K), Amgen Inc. (U.S.), Allergan plc. (U.K), and AbbVie, Inc. (U.S.). Key players have incorporated several strategies to stay ahead in the competition, such as strategic alliances, partnerships, mergers acquisitions, and product launches.

Market Segmentation 

The Market Research Future report provides an all-inclusive segmental analysis of the global kidney infection market based on end user, treatment, and diagnosis.

  • By Diagnosis, the global kidney infection market is segmented into imaging test and dipstick urine test. The imaging test is again segmented into voiding cystourethrogram, CT scan, ultrasound, and others.
  • By Treatment, the global kidney infection market is segmented into kidney transplants, dialysis, medication, and others. The medication segment is again segmented into non-steroidal anti-inflammatory drugs (NSAIDs) and antibiotics.
  • By End user, the global kidney infection market is segmented into research institutes, nephrology center, hospitals and clinics, and others.

Regional Analysis 

By region, the global kidney infection market report covers the latest trends and growth opportunities across the Americas, the Asia Pacific (APAC), Europe, and the Middle East and Africa (MEA).

The Americas will lead the market during the forecast period for high health care spending, increasing support from the government for RD activities, rising patient population for kidney infection, and the availability of advanced medical devices both for diagnosis as well as treatment of kidney infection including dialysis machine, and rising patient population for kidney infection. Moreover, the concentration of key companies and increased research and development activities are also adding to the global kidney infection market growth in the region.

The global kidney infection market in Europe is predicted to hold the second-largest share in the market during the forecast period for huge availability of funds for RD activities, increasing focus on new drug development, and increasing support from the government for research and development. Moreover, the increasing number of specialty services provided by different healthcare providers in the region is also adding market growth. France as well as Germany are the leading contributors in the region owing to increasing focus on hospital infrastructure and rising investment in the healthcare sector.

Get Access Full Report @ https://www.marketresearchfuture.com/reports/kidney-infection-market-5192 

The global kidney infection market in the APAC region will grow at the fastest pace during the forecast period for high healthcare expenditure and the presence of rapidly expanding healthcare technology. The increasing patient population in India and the growing demand for quality healthcare devices are also adding to the market growth.

The global kidney infection market in the MEA will have a small share in the market during the forecast period for the unavailability of medical devices that are technologically advanced, limited medical facilities, and less availability of funds.

5 Görüntüler